Mannatech Inc

Mannatech Inc(MTEX)股票分析

$8.110

+0.050 (+0.62%)收盘时

Loading chart…
最高
8.640
开盘
8.290
成交量加权均价
8.17
成交量
10.84K
市值
13.10M
最低
7.770
成交额
88.58K
企业价值/息税折旧摊销前利润(TTM)
0.00

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.

AI 分析 of Mannatech Inc (MTEX)

持有

Mannatech Inc is not a strong buy right now due to its current price of $8.11, which is significantly below its 52-week high of $9.97. The RSI of 41.05 indicates the stock is nearing oversold territory, but the recent 5-day change of -4.25% suggests downward momentum. The upcoming earnings report on November 11 could provide more clarity on its financial health, but the company has faced declining revenues, with a 6.2% year-over-year decrease reported for Q1 2026.

估值指标

Mannatech Inc(MTEX)当前预期市盈率为 9.57,5 年平均预期市盈率为 1.70。

预期市盈率

严重高估
5 年均值 P/E
1.70
当前P/E
9.57
高估
5.22
低估
-1.83

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 MTEX 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%MTEX

$9.48

情景价格

基

基准

基准 · 50%MTEX

$7.93

情景价格

悲

悲观

悲观 · 25%MTEX

$7.87

情景价格

事件时间线

2026-09-24 (ET)

10:00:00

Mannatech Trading Halted Due to Volatility

2026-09-01 (ET)

16:30:00

Mannatech Board Chairman Change Announced

2026-08-14 (ET)

14:30:00

Mannatech Trading Resumes

14:30:00

Mannatech Trading Halted Due to Volatility

2026-04-07 (ET)

16:00:00

Mannatech Trading Halted Due to Volatility

资讯

MTEX 常见问题 —— 由 Alphio AI 解答

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Mannatech Inc is not a strong buy right now due to its current price of $8.11, which is significantly below its 52-week high of $9.97. The RSI of 41.05 indicates the stock is nearing oversold territory, but the recent 5-day change of -4.25% suggests downward momentum. The upcoming earnings report on November 11 could provide more clarity on its financial health, but the company has faced declining revenues, with a 6.2% year-over-year decrease reported for Q1 2026.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易